Bilateral Sacroiliac Joint (SIJ) Injection in Lumbar Disc Prolapse

Sohag University

Status: Completed

Conditions: Spine Stiffness; Low Back Pain, Mechanical; Lumbar Disc Herniation; Sciatica

Treatments: Procedure: Bilateral SIJ injection

Study type: Interventional

Funder types: Other

Identifiers

NCT04326699

15/3/2020

Details and patient eligibility

About

Bilateral sacroiliac joint injection in symptomatic lumbar disc prolapse under ultrasound guidance and studying the effect of this technique on pain, spine mobility and activity of daily living.

Full description

86 Patients with lumbar disc prolapse diagnosed by either MRI or CT will be included. All of them aged > 18 years with no special condition for the duration of disc prolapse. All of them had clinical manifestations in the form of mechanical low back pain or sciatica or limited spine mobility. All participants had no or poor response to conservative treatment. Previous surgery, severe facet arthropathy, ankylosing spondylitis, sensory or motor deficit and wedge fracture were considered as exclusion criteria. Distraction, compression, thigh thrust, and sacral thrust were used to assess SIJ dysfunction only at baseline before injection. Fingertip to floor and Oswestry disability index (ODI) were used to assess mobility and function of the spine at baseline (before and after injection) and after 2 and 16 weeks. Visual Analogue Scale (VAS) was used for pain appraisal at the same intervals. Participants will be randomly assigned into active and control group using 1:1 allocation. In the active group bilateral SIJ injection will be performed under ultrasound US guidance. Under US guidance a 22G spinal needle, where 1 mL 2 % lidocaine hydrochloride (xylocaine, AstraZeneca) mixed with triamcinolone 40 milligrams (Kenacort, Bristol Myers Squip) will be injected in each SIJ.

Enrollment: 86 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Lumbar disc prolapse diagnosed by either MRI or CT were included.
• All of them aged > 18 years
• No special condition for the duration of disc prolapse.
• All of them had clinical manifestations in the form of mechanical low back pain or sciatica or limited spine mobility.
• All participants had no or poor response to conservative treatment

Exclusion criteria

• Previous surgery
• Severe facet arthropathy
• Ankylosing spondylitis
• Sensory or motor deficit
• Wedge fracture

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

86 participants in 2 patient groups

Sacroiliac joint injection group

Active Comparator group

Description:

The active group will receive bilateral sacroiliac joint injection of 1 mL 2 % lidocaine hydrochloride (xylocaine, AstraZeneca) mixed with triamcinolone 40 milligrams (Kenacort, Bristol Myers Squip) under ultrasound guidance.

Treatment:

Procedure: Bilateral SIJ injection

control group

No Intervention group

Description:

The other group will not receive the sacroiliac joint injection